Solvay cuts 2026 outlook. JP Morgan target for Solvay stock is EUR 28.50

Published on 10/26/2026 at 10:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Solvay cut EBITDA guidance to EUR 720-740 million on October 19, 2026. Solvay stock costs EUR 23.20 on October 26, 2026 versus JP Morgan's EUR 28.50 target.

Guidance and analyst revision

Solvay posted EUR 1.03 billion in underlying net sales for the third quarter of 2026 on October 19, 2026.
Full-year underlying EBITDA guidance stands at EUR 720 million to EUR 740 million after the October 19, 2026 update.
Solvay stock trades at EUR 23.20 at 10:38 a.m. CEST at Lang & Schwarz on October 26, 2026.

Aquarell-Illustration der Brüsseler Skyline mit Fluss und weichen Pastellfarben — Aquarellmalerei zeigt Brussels Skyline und Fluss, weiche Farbverläufe, Solvay S.A. Hauptsitz Ambiente, BE0003470755 gehört dazu, Illustration mit AI erstellt.

Solvay (ISIN BE0003470755) reported preliminary third-quarter underlying net sales of EUR 1.03 billion and underlying EBITDA of EUR 173 million on October 19, 2026. The company cut its full-year underlying EBITDA guidance to EUR 720 million to EUR 740 million, while JP Morgan reduced its price target from EUR 30.00 to EUR 28.50 on October 20, 2026, according to Zonebourse.

Guidance reflects the Q3 pressure

The revised outlook followed a difficult third quarter. GlobeNewswire, carrying Solvay's release dated October 19, 2026, said the Middle East conflict affected performance and that a peroxide plant at the Sadara complex in Jubail, Saudi Arabia, remained shut down. Underlying free cash flow to Solvay shareholders from continuing operations was EUR 54 million in the quarter.

The updated full-year free cash flow outlook is EUR 120 million to EUR 150 million, net of EUR 90 million in transformation expenses. The range excludes potential revenue or recovery measures linked to Sadara for the remainder of 2026, making the plant disruption the central operating risk in the revised plan.

What does the target cut mean?

JP Morgan kept an overweight recommendation while cutting its target from EUR 30.00 to EUR 28.50, a EUR 1.50 reduction dated October 20, 2026. The change places the analyst view above the current euro quotation, but the lower target also shows how the guidance reset has altered expectations.

Next results date

Solvay is scheduled to publish its final third-quarter 2026 results on November 4, 2026, according to the company's investor-relations release. That report will replace the preliminary figures and provide the next detailed test of the revised outlook.

Stock price and company profile

Solvay operates in chemicals, including soda ash, peroxides, silica and specialty chemical solutions. The company said its 2025 underlying net sales were EUR 4.3 billion in the October 19, 2026 release, providing scale for the comparison with the EUR 1.03 billion preliminary quarterly figure.

The stock was trading at EUR 23.20 at Lang & Schwarz on October 26, 2026 at 10:38 a.m. CEST. The quotation is in the regular Xetra-oriented trading phase used for this German market perspective. The further course of trading is shown by the continuously updated real-time quote of Solvay stock.